COVID-19 Variant Network – Production of a recombinant S ( spike ) protein vaccine against SARS-CoV-2 and emerging coronaviruses
Houghton, Michael |
University of Alberta | Operating Grant | $100,000
CIHR Alberta 2021
Read More
Opioid Use Disorder Care during COVID‑19 Disruptions
McLane, Patrick |
University of Alberta | Operating Grant | $199,806
CIHR Alberta 2020
Read More
COVID-19 Associated Outcomes of Critical Illness in Patients with Frailty
Rewa, Oleksa G |
University of Alberta | Operating Grant | $46,194
CIHR Alberta 2020
Rational design and standardization of serology diagnostics using immunoaffinity-targeted proteomics assays
Drabovich, Andrei P |
University of Alberta | Operating Grant | $215,500
CIHR Alberta 2020
Read More
COVID-19 Variant Supplement – Production of a recombinant S ( spike ) protein vaccine against SARS-CoV-2 and emerging coronaviruses
Houghton, Michael |
University of Alberta | Operating Grant | $50,000
CIHR Alberta 2021
Read More
Overcoming emerging COVID‑19 challenges with relatable science: Developing and evaluating knowledge tools for Canadians
Scott, Shannon D |
University of Alberta | Operating Grant | $272,470
CIHR Alberta 2021
Read More
Implementing the Provincial Post COVID‑19 Rehabilitation Framework for Screening & Transitions in Alberta: A Pragmatic Evaluation
Ho, Chester |
University of Alberta | Operating Grant | $499,883
CIHR Alberta 2021
Read More
Feeding EPA and DHA Improve Clinical Symptoms Associated with COVID‑19 Infection
Mazurak, Vera C |
University of Alberta | Project Grant | $344,250
CIHR Alberta 2021
Read More
The impact of COVID‑19 on the health of physicians, nurses and other healthcare workers: an interprovincial cohort study
Cherry, Nicola |
University of Alberta | Operating Grant | $1,023,330
CIHR Alberta 2020
Read More
Deciphering immune responses in COVID‑19 patients to identify immune correlates of protection and susceptibility for targeted therapeutics
Elahi, Shokrollah |
University of Alberta | Project Grant | $1,071,000
CIHR Alberta 2021
Read More
